Human LILRB2/CD85d/ILT4 Protein, Accession: Q8N423

/在： /通过：
  • 产品概述
  • 产品规格
  • 运输及存储
  • 品牌声明

    • 产品概述

    产品描述

    Recombinant Human LILRB2/CD85d/ILT4 Protein is expressed from HEK293 with mFc (IgG1) tag at the C-terminal.It contains Gln22-His458.

    Biotinylated

    产品规格

    靶点

    LILRB2/CD85d/ILT4

    分子别名

    CD85d; ILT4; ILT-4; ILT4CD85d; LILRB2; LIR2; MIR10

    Accession

    Q8N423

    种属

    Human

    蛋白序列

    Gln22-His458

    分子量

    The protein has a predicted MW of 73.6 kDa. Due to glycosylation, the protein migrates to 80-110 kDa based on Tris-Bis PAGE result.

    活性

    Immobilized Human LILRB2, mFc Tag at 0.5ug/ml (100ul/well) on the plate. Dose response curve for Anti-LILRB2 Antibody, hFc Tag with the EC50 of 11.4ng/ml determined by ELISA (QC Test). See testing image for detail.

    产品标签

    C-mFc

    表达系统

    HEK293

    纯度

    > 95% as determined by Tris-Bis PAGE;> 95% as determined by HPLC

    内毒素

    Less than 1EU per ug by the LAL method.

    运输及存储

    产品外观

    Lyophilized

    运输条件

    Shipped at ambient temperature.

    制剂

    Lyophilized from 0.22um filtered solution in PBS (pH 7.4). Normally 5% trehalose is added as protectant before lyophilization.

    复溶

    Centrifuge tubes before opening. Reconstituting to a concentration more than 100 ug/ml is recommended. Dissolve the lyophilized protein in distilled water.

    存储和稳定性

    Reconstituted protein stable at -80°C for 12 months, 4°C for 1 week. Use a manual defrost freezer and avoid repeated freeze-thaw cycles.

    该产品的品牌ChemWhat是Watson的注册商标，由Watson授权江苏沃尔森在中国大陆地区使用，点此访问ChemWhat官网。